ArticleFrontiers in oncology2025

Case Report: Unlocking opportunities in HER2-targeted antibody-drug conjugates for bulky leptomeningeal metastatic breast cancer.

Alessandro Leal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.